This inventor holds 8 USPTO granted patents and 3 EPO patents. Top assignees: Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ag. Active years: 2007-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Staten Island, NY (US) (2007 - 2009)
- Bloomfield, NJ (US) (2008 - 2016)
Company Filing History:
Years Active: 2007-2016
Title: The Innovations of John Anthony Moliterni
Introduction
John Anthony Moliterni is a distinguished inventor based in Bloomfield, NJ, United States. With a remarkable portfolio encompassing eight patents, his work primarily focuses on innovative compounds with therapeutic applications. His contributions to the field of pharmacology and chemistry have the potential to greatly impact the treatment of various medical conditions.
Latest Patents
Among his latest patents, Moliterni has developed compounds described as substituted hetero-azepinones. These compounds hold significant promise in the pharmaceutical landscape. Additionally, he has patented substituted hydantoins, which involve methods for their preparation and use. Notably, these compounds are poised to assist in treating diseases characterized by the hyperactivity of MEK. This positions them as useful in the treatment of cancer, cognitive disorders, central nervous system disorders, as well as inflammatory and autoimmune diseases.
Career Highlights
Throughout his career, John Moliterni has made invaluable contributions while working for renowned companies such as Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His expertise in developing innovative therapeutic compounds has led to advancements in the medical field, making him a prominent figure among his contemporaries.
Collaborations
In his professional journey, Moliterni has collaborated with esteemed colleagues, including Norman Kong and Nicholas J. S. Huby. These partnerships have facilitated the sharing of ideas and the advancement of research, further enriching his contributions to the domain of inventions and patents.
Conclusion
John Anthony Moliterni's work exemplifies the spirit of innovation and dedication to improving health outcomes through scientific advancement. His patents reflect a commitment to addressing critical health challenges and enhancing the potential for therapeutic interventions in various diseases. As he continues to innovate, the impact of his work is likely to resonate within the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile